ALMR
Alamar Biosciences, Inc. NASDAQ Listed Apr 17, 2026$32.46
Mkt Cap $2.2B
52w Low $18.85
69.1% of range
52w High $38.54
50d MA $30.58
200d MA $26.48
P/E (TTM)
—
EV/EBITDA
—
P/B
—
Debt/Equity
—
ROE
—
P/FCF
—
RSI (14)
65.40
ATR (14)
$2.23
Beta
0.00
50d MA
$30.58
200d MA
$26.48
Avg Volume
432.5K
Alamar Biosciences is a commercial-stage proteomics company focused on ultra-sensitive, multiplexed protein detection for research and future clinical applications. Its platform combines proprietary instruments, consumables, and software to provide an end-to-end system for measuring multiple low-abundance proteins across research and potential clinical applications.
47071 Bayside Parkway · Fremont, CA 94538 · US
Data updated apr 24, 2026 5:24pm
· Source: financialmodelingprep.com